Skip to main content
Terug
Watch Compare

ORTHOPEDIATRICS CORP

Datakwaliteit: 100%
KIDS
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 15,97
▼ € 0,04 (-0,25%)
Marktkapitalisatie: 403,70 M
Prijs
€ 15,97
Marktkapitalisatie
403,70 M
Dagbereik
€ 15,70 — € 16,09
52-Weeksbereik
€ 14,91 — € 23,70
Volume
65.575
Openen € 15,83
50D / 200D Gem.
€ 17,09
6,53% below
50D / 200D Gem.
€ 18,61
14,17% below

Quick Summary

Belangrijkste Punten

Revenue grew 24,60% annually over 5 years — strong growth
Debt/Equity of 0,30 — conservative balance sheet
Negative free cash flow of -15,96 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,15%
Capital efficient — spends only 4,70% of revenue on capex

Groei

Revenue Growth (5Y)
24,60%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)15,45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-11,25%
Boven sectorgemiddelde (-53,41%)
ROIC-6,70%
Net Margin-16,78%
Op. Margin-16,60%

Veiligheid

Debt / Equity
0,30
Onder sectorgemiddelde (0,31)
Current Ratio7,40
Interest Coverage-1453,26

Waardering

PE (TTM)
-10,18
Onder sectorgemiddelde (-1,48)
P/B Ratio1,16
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -10,2 -1,5
P/B 1,2 1,6
ROE % -11,3 -53,4
Net Margin % -16,8 -41,5
Rev Growth 5Y % 24,6 1,8
D/E 0,3 0,3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,04% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,03% weight
EES logo EES WisdomTree U.S. SmallCap Fund
0,02% weight
IWV logo IWV iShares Russell 3000 ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 15,45% Revenue Growth (3Y) 26,06%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 24,60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 236,35 M Net Income (TTM) -39,65 M
ROE -11,25% ROA -7,95%
Gross Margin 73,05% Operating Margin -16,60%
Net Margin -16,78% Free Cash Flow (TTM) -15,96 M
ROIC -6,70% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,30 Current Ratio 7,40
Interest Coverage -1453,26 Asset Turnover 0,47
Working Capital 212,62 M Tangible Book Value 182,43 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10,18 Forward P/E N/A
P/B Ratio 1,16 P/S Ratio 1,71
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3,95%
Market Cap 403,70 M Enterprise Value 492,19 M
Per Share
EPS (Diluted TTM) -1,69 Revenue / Share 9,35
FCF / Share -0,63 OCF / Share -0,19
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4,70% FCF Conversion 40,26%
SBC-Adj. FCF -33,25 M Growth Momentum -9,15

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 236,35 M 204,73 M 148,73 M 122,29 M 98,05 M
Net Income -39,65 M -37,82 M -20,97 M 1,26 M -16,26 M
EPS (Diluted) -1,69 -1,64 -0,92 0,06 -0,84
Gross Profit 172,66 M 148,60 M 111,25 M 90,66 M 73,40 M
Operating Income -39,24 M -35,01 M -26,75 M -25,40 M -18,02 M
EBITDA — — — — —
R&D Expenses 9,10 M 11,03 M 10,20 M 8,01 M 5,54 M
SG&A Expenses — — — — —
D&A 21,12 M 19,08 M 17,39 M 13,10 M 10,68 M
Interest Expense 27.000,0 35.000,0 42.000,0 -2,42 M -2,25 M
Income Tax 460.000,0 -4,11 M -338.000,0 -4,95 M -1,13 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 508,63 M 473,21 M 438,75 M 427,73 M 304,27 M
Total Liabilities 162,03 M 118,64 M 61,72 M 49,08 M 78,91 M
Shareholders' Equity 346,60 M 354,57 M 377,03 M 378,65 M 225,37 M
Total Debt 106,01 M 77,48 M 11,06 M 907.000,0 1,04 M
Cash & Equivalents 19,56 M 43,82 M 31,06 M — 7,64 M
Current Assets 256,42 M 237,17 M 226,50 M 226,72 M 133,65 M
Current Liabilities 46,20 M 33,96 M 41,67 M 30,87 M 29,72 M